GMT 15:13 20.10.2021Copy the link
Arabic – News, Opinions & Radio Sputnik
The US Food and Drug Administration (FDA) on Wednesday approved a new drug for one type of breast cancer, a development that one scientist says is the first real progress in 20 years.
The new drug “will change the course of treatment,” said Giuseppe Corigliano, head of early drug development at the European Institute of Oncology in Milan, Italy.
The drug called abemaciclib — the brand name Verzenio — is now approved for patients with early HR+, ER2 breast cancer, which makes up 70% of all breast cancers.
October every year is Breast Cancer Awareness Month in all countries of the world.
The month of October helps to increase interest in this disease and provide the necessary support to raise awareness of its seriousness and early detection and treatment, as well as providing patients with it with palliative care, according to the World Health Organization.
Sputnik / M.HASSAN
“The 12 best foods for women”… “Protects them from breast cancer and strengthens bones”